ATA100695A - Prothrombin-derivate - Google Patents
Prothrombin-derivateInfo
- Publication number
- ATA100695A ATA100695A AT0100695A AT100695A ATA100695A AT A100695 A ATA100695 A AT A100695A AT 0100695 A AT0100695 A AT 0100695A AT 100695 A AT100695 A AT 100695A AT A100695 A ATA100695 A AT A100695A
- Authority
- AT
- Austria
- Prior art keywords
- prothromine
- derivatives
- prothromine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/974—Thrombin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0100695A AT404357B (de) | 1995-06-13 | 1995-06-13 | Prothrombin-derivate |
AU58871/96A AU700631B2 (en) | 1995-06-13 | 1996-06-12 | Prothrombin derivatives |
US08/952,967 US6086871A (en) | 1995-06-13 | 1996-06-12 | Prothrombin derivatives |
HU9900506A HUP9900506A3 (en) | 1995-06-13 | 1996-06-12 | Prothrombin derivatives |
PCT/AT1996/000105 WO1996041868A2 (de) | 1995-06-13 | 1996-06-12 | Prothrombin-derivate |
CZ974020A CZ402097A3 (cs) | 1995-06-13 | 1996-06-12 | Deriváty prothrombinu |
EP96915903A EP0833897A2 (de) | 1995-06-13 | 1996-06-12 | Prothrombin-derivate |
JP9502398A JPH11507542A (ja) | 1995-06-13 | 1996-06-12 | プロトロンビン誘導体 |
CA002224634A CA2224634A1 (en) | 1995-06-13 | 1996-06-12 | Prothrombin derivatives |
AT180596A AT404516B (de) | 1995-06-13 | 1996-10-14 | Vorrichtung zur quantifizierung von prothrombin-derivaten |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0100695A AT404357B (de) | 1995-06-13 | 1995-06-13 | Prothrombin-derivate |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA100695A true ATA100695A (de) | 1998-03-15 |
AT404357B AT404357B (de) | 1998-11-25 |
Family
ID=3504770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0100695A AT404357B (de) | 1995-06-13 | 1995-06-13 | Prothrombin-derivate |
Country Status (9)
Country | Link |
---|---|
US (1) | US6086871A (de) |
EP (1) | EP0833897A2 (de) |
JP (1) | JPH11507542A (de) |
AT (1) | AT404357B (de) |
AU (1) | AU700631B2 (de) |
CA (1) | CA2224634A1 (de) |
CZ (1) | CZ402097A3 (de) |
HU (1) | HUP9900506A3 (de) |
WO (1) | WO1996041868A2 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040032147A (ko) * | 2001-07-06 | 2004-04-14 | 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 | 유전자 재조합 기술에 의한 인간 트롬빈 제조 방법 |
AU2008202376B2 (en) * | 2001-07-06 | 2011-02-10 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Process for producing human thrombin by gene modification technique |
US20030099957A1 (en) * | 2001-09-28 | 2003-05-29 | Vitivity, Inc. | Diagnosis and treatment of vascular disease |
WO2006104398A1 (en) * | 2005-03-26 | 2006-10-05 | Protemix Corporation Limited | Copper antagonist compositions |
AU2007320353A1 (en) | 2006-11-15 | 2008-05-22 | Fujimori Kogyo Co., Ltd. | Thrombin mutant |
PL2193196T3 (pl) | 2007-09-28 | 2017-07-31 | Portola Pharmaceuticals, Inc. | Antidotum na czynnik inhibitora XA oraz sposoby jego stosowania |
CA2743999A1 (en) * | 2008-10-27 | 2010-06-03 | Trustees Of Tufts College | Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds, and uses thereof |
JP5709316B2 (ja) | 2008-11-14 | 2015-04-30 | ポートラ ファーマシューティカルズ, インコーポレイテッド | 第Xa因子阻害剤のための解毒剤および血液凝固剤と組み合わせて該解毒剤を使用する方法 |
PT2414517T (pt) | 2009-03-30 | 2016-12-27 | Portola Pharm Inc | Antídotos para inibidores do fator xa e métodos de utilização dos mesmos |
JP6163304B2 (ja) | 2009-07-15 | 2017-07-12 | ポートラ ファーマシューティカルズ, インコーポレイテッド | 第Xa因子インヒビターの解毒剤の単位用量処方物およびその使用方法 |
AR079944A1 (es) | 2010-01-20 | 2012-02-29 | Boehringer Ingelheim Int | Anticuerpo neutralizante de la actividad de un anticoagulante |
EP2471945A1 (de) * | 2010-12-30 | 2012-07-04 | Siemens Healthcare Diagnostics Products GmbH | Verfahren zur Bestimmung von Inhibitoren der Gerinnung |
MX2013011092A (es) | 2011-03-30 | 2013-12-06 | Boehringer Ingelheim Int | Antidotos anticoagulantes. |
CA2870211A1 (en) * | 2012-04-17 | 2013-10-24 | Aarhus Universitet | Sorcs1 for use in the treatment of obesity and overweight |
GB2504499A (en) * | 2012-07-31 | 2014-02-05 | Baxter Healthcare Sa | Selective measurement of active human protease coagulation factors |
EA202190813A1 (ru) | 2014-05-26 | 2021-12-31 | Академиш Зикенхёйс Лейден | Прогемостатические белки для лечения кровотечений |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5167960A (en) * | 1988-08-03 | 1992-12-01 | New England Deaconess Hospital Corporation | Hirudin-coated biocompatible substance |
US5112615A (en) * | 1988-08-03 | 1992-05-12 | New England Deaconess Hospital Corporation | Soluble hirudin conjugates |
CA2000887A1 (en) * | 1988-11-01 | 1990-05-01 | Cecilia S.L. Ku | Thromboresistant materials and methods for making same |
DE69017236T3 (de) * | 1989-01-25 | 1999-11-25 | Novartis Ag, Basel | Monoklonale Antikörper, spezifisch für Hirudin. |
DE69101634D1 (de) * | 1990-01-26 | 1994-05-11 | Immuno Ag Wien | Rekombinant hergestellte blutfaktoren, verfahren zur exprimierung besagter blutfaktoren sowie in besagtem prozess verwendeter rekombinanter vaccina-virus. |
US5688768A (en) * | 1991-02-19 | 1997-11-18 | Cor Therapeutics, Inc. | Recombinant thrombin receptor and related pharmaceuticals |
DE4203965A1 (de) * | 1992-02-11 | 1993-08-12 | Max Planck Gesellschaft | Antidot fuer hirudin und synthetische thrombininhibitoren |
US6110721A (en) * | 1993-11-12 | 2000-08-29 | Gilead Sciences, Inc. | Polypeptides and coagulation therapy |
AT401270B (de) * | 1994-09-26 | 1996-07-25 | Immuno Ag | Verfahren zur quantifizierung von genomischer dna |
-
1995
- 1995-06-13 AT AT0100695A patent/AT404357B/de not_active IP Right Cessation
-
1996
- 1996-06-12 EP EP96915903A patent/EP0833897A2/de not_active Withdrawn
- 1996-06-12 CZ CZ974020A patent/CZ402097A3/cs unknown
- 1996-06-12 US US08/952,967 patent/US6086871A/en not_active Expired - Lifetime
- 1996-06-12 WO PCT/AT1996/000105 patent/WO1996041868A2/de not_active Application Discontinuation
- 1996-06-12 CA CA002224634A patent/CA2224634A1/en not_active Abandoned
- 1996-06-12 HU HU9900506A patent/HUP9900506A3/hu unknown
- 1996-06-12 JP JP9502398A patent/JPH11507542A/ja active Pending
- 1996-06-12 AU AU58871/96A patent/AU700631B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
HUP9900506A2 (hu) | 1999-06-28 |
CZ402097A3 (cs) | 1998-04-15 |
AU700631B2 (en) | 1999-01-07 |
CA2224634A1 (en) | 1996-12-27 |
AT404357B (de) | 1998-11-25 |
AU5887196A (en) | 1997-01-09 |
WO1996041868A2 (de) | 1996-12-27 |
WO1996041868A3 (de) | 1997-04-10 |
JPH11507542A (ja) | 1999-07-06 |
HUP9900506A3 (en) | 2001-10-29 |
EP0833897A2 (de) | 1998-04-08 |
US6086871A (en) | 2000-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69522717D1 (de) | Chinazolinderivate | |
DE69611361D1 (de) | Chinazolin-derivate | |
NO974103L (no) | Arylsulfonylaminohydroksamsyre-derivater | |
DE69610698D1 (de) | Chinazolin-derivate | |
PT833828E (pt) | Derivados de rapamicina | |
DE59608860D1 (de) | Bogenrotationsdruckmaschine | |
BR9611834A (pt) | Derivados de oximetóxi-3-aril-pirona | |
ATE199150T1 (de) | Diphenylmethylenpiperidin-derivate | |
NO964667D0 (no) | Purin-6-on-derivater | |
DE69605810D1 (de) | Hubtor | |
DE69601527D1 (de) | Pyrrolylbenzimidazol-Derivate | |
ATA100695A (de) | Prothrombin-derivate | |
PT856007E (pt) | Derivados de ciclopeptidos | |
ATE240307T1 (de) | Diarylalkenylamin-derivate | |
DE69627830D1 (de) | Pyrazol-derivate | |
NO961404D0 (no) | 4-indolylpiperazinyl-derivater | |
DK0723963T3 (da) | 4-Amino-benzoylguanidin-derivater | |
DE59610106D1 (de) | Fluorbenzylether-Derivate | |
ATE177102T1 (de) | Chromanderivate | |
DE69624122D1 (de) | Aza-anthracyclinone-derivate | |
BR9603508A (pt) | Derivados de alquenil-benzoilguanidina | |
DE69620513D1 (de) | Zelluloseesterwundverband | |
DE59607055D1 (de) | 4-Mercapto-benzoylguanidin-Derivate | |
DE69620514D1 (de) | 5-aminoflavon-derivate | |
ATA45796A (de) | Lysin-prolin-derivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK07 | Expiry |
Effective date: 20150613 |